Skip to search.
 TSX Down 0.06% TSX Ventures Up 0.32%

OncoGenex Pharmaceuticals, Inc. (OGXI)

-NasdaqCM
2.07 Down 0.08(3.72%) 10:28AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:2.15
Open:2.14
Bid:2.09 x 1100
Ask:2.10 x 500
1y Target Est:5.45
Beta:0.6
Earnings Date:Apr 28 - May 4 (Est.)
Day's Range:2.06 - 2.14
52wk Range:1.92 - 11.84
Volume:20,704
Avg Vol (3m):243,046
Market Cap:44.05M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
OGXIDown 3.72%44.05M
BMYDown 1.00%105.53B
CELGDown 1.98%90.47B
PFEDown 1.14%210.80B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.79
Quarterly EPS Est (Mar-15) :-0.34
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback